| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2524123 | Biomedicine & Pharmacotherapy | 2015 | 6 Pages |
Abstract
Gastric cancer is the second-leading cause of cancer death in Asia. Despite improvement of therapies, the outcome in patients remains extremely poor because of metastasis. In the present study, we found that LIMK1 is overexpressed in gastric cancer, and its expression level correlate with tumor size, lymph node metastasis and TNM stage. Knockdown of LIMK1 expression could inhibit cell proliferation, migration and invasion in vitro, as well as suppress the activation of FAK/paxillin pathway. Moreover, knockdown of LIMK1 expression retarded tumor growth and peritoneal ametastasis in vivo. This highlights that LIMK1 might be used as a potential target in the treatment of gastric cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Tiangeng You, Wei Gao, Jun Wei, Xiaoli Jin, Zhongxin Zhao, Congjun Wang, Yang Li,